QUR
- Product code
- QUR
- Device name
- Prescription Spectacle Lenses To Reduce The Progression Of Myopia
- Device class
- Class 2
- 21 CFR
- 21 CFR 886.5845
- Medical specialty
- Ophthalmic
- Marketing pathway
- 510(K)
- 510(k) clearances (last 3 years)
- 1
- Summaries archived here
- 0 (direct download)
- 510(k) clearances (all years, FDA)
- 1 (all years; only the last 3 years are listed here)
FDA classification definition
Prescription spectacle lenses to reduce the progression of myopia consist of spectacle lenses with additional physical optical design lens elements. In addition to optical correction of myopic refractive error, these lenses are intended to be used by children who have myopia to reduce the rate of myopia progression. The lenses are mounted within a spectacle frame classified under § 886.5842.
510(k) clearances, last 3 years (1)
| Number | Decision date | Applicant | Device name | Summary |
|---|---|---|---|---|
| DEN250016 | 2025-09-25 | Essilor Of America, Inc. | Essilor® Stellest® | — |
Official FDA classification page: QUR
Classification and pathway per current FDA publications. Data from openFDA (CC0).